Crossmark

Methotrexate use, not interleukin 33, is associated with lower carotid intima-media thickness in patients with rheumatoid arthritis

Crossref DOI link: https://doi.org/10.1186/s42358-019-0060-1

Published Online: 2019-04-03

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pinto, Maria Raquel Costa http://orcid.org/0000-0001-7093-830X
Kakehasi, Adriana Maria

Souza, Adriano José

Tavares, Wilson Campos Jr

Rocha, Monaliza Angela

Trant, Cyntia Gabriele Michel Cardoso

Andrade, Marcus Vinicius
Funding

Funding for this research was provided by:

Fundação de Amparo à Pesquisa do Estado de Minas Gerais (APQ-00765-13)

Conselho Nacional de Desenvolvimento Científico e Tecnológico (473390/2013-2)
License Information

Text and Data Mining valid from 2019-04-03
More Information

Article History

Received: 15 August 2018

Accepted: 26 March 2019

First Online: 3 April 2019

Ethics approval and consent to participate

: Prior to undergoing any procedures, all of the patients who were included the present study signed an informed consent form approved by the research ethics committee at the Universidade Federal de Minas Gerais. This study was conducted in accordance with the ethical standards of the local committee and with the Declaration of Helsinki.

: Not applicable.

: The authors declare that they have no competing interest.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.